[Childhood obesity and coronary artery disease: a Mendelian randomization study]

L X Meng1, X M Que, X Gao

  • 1School of Public Health, Shanxi Medical University, Taiyuan 030001, China.

Insights

Childhood obesity causally increases the risk of developing coronary artery disease (CAD) in adulthood. A 1-unit increase in childhood BMI significantly raises the odds of adult CAD by 37%.

Area of Science:

  • Genetics
  • Cardiovascular Disease Epidemiology
  • Pediatric Health

Background:

  • Childhood obesity is a growing public health concern.
  • The long-term cardiovascular consequences of childhood obesity require further investigation.
  • Establishing a causal link between childhood obesity and adult coronary artery disease (CAD) is crucial for preventative strategies.

Purpose of the Study:

  • To determine the causal effect of childhood obesity on the risk of developing coronary artery disease (CAD) in adulthood.
  • To utilize the Mendelian randomization (MR) method for robust causal inference.
  • To quantify the association between childhood body mass index (BMI) and adult CAD risk.

Main Methods:

  • Employed Mendelian randomization (MR) analysis using genetic variants associated with childhood BMI as instrumental variables.
  • Utilized large-scale genetic data from the Early Growth Genetics Consortium and the Genetic Investigation of Anthropometric Traits Consortium.
  • Assessed potential pleiotropy using MR-Egger regression and conducted primary analysis with the mode-based estimate method.

Main Results:

  • No significant pleiotropy was detected among the selected genetic variants (MR-Egger intercept: -0.008 to 0.018).
  • A 1-unit increase in childhood BMI (kg/m²) was associated with a 37% average increase in the risk of adult CAD (OR=1.37, 95% CI: 1.09-1.72).
  • The findings provide strong evidence for a causal relationship.

Conclusions:

  • Childhood obesity is causally linked to an increased risk of developing coronary artery disease (CAD) in adulthood.
  • This study reinforces the importance of early life weight management for long-term cardiovascular health.
  • The Mendelian randomization approach offers a reliable method for investigating such causal associations.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
340
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
601
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
241